Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD Granted US FDA Fast Track for RAD101 Metastases Imaging Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Radiopharm Theranostics Granted U.S. Food and Drug Administration Fast Track Designation for RAD101 Imaging in Brain Metastases June 12, 2025 Nuclear Fuels Commences 2025 Kaycee Uranium Project Drill Program June 12, 2025 Peter Krauth: Silver Price Running, Stocks Exploding — What’s Next? June 12, 2025
Radiopharm Theranostics Granted U.S. Food and Drug Administration Fast Track Designation for RAD101 Imaging in Brain Metastases June 12, 2025